SEP 4, 2026 · PHASE 2 TRIAL
Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC
ClinicalTrials.gov
This is a recruiting Phase 2 trial with no posted results; it represents planned evidence, not completed evidence, and cannot yet inform clinical practice.
Reported
Planned enrollment128
PhasePhase 2
Primary endpointProgression-free Survival at 2 Years